{"nct_id":"NCT00486720","title":"Phase IIa Vorinostat (MK0683, Suberoylanilide Hydroxamic Acid (SAHA)) Study in Lower Risk Myelodysplastic Syndromes (0683-064)","status":"TERMINATED","status_verified_date":"2015-06","start_date":"2007-06","start_date_type":null,"primary_completion_date":"2009-07","primary_completion_date_type":"ACTUAL","completion_date":"2009-07","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["MRK"]}